Specifically, knockdown of MLK3 was found to reduce the invasive aggressiveness of glioma cells by inhibiting estimated glomerular filtration rate (EGFR)-mediated jun N-terminal kinase (JNK) activation [22]. The gene discussed is MAP3K11; the disease is central nervous system cancer.